Mechanism of the hypocalcemic agent WR-2721 and its acute and chronic application in eu- and hyperparathyroidism.
D004999:Amifostine / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001862:Bone Resorption / Q000187:drug effects; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy; D006961:Hyperparathyroidism / Q000188:drug therapy*; D008274:Magnesium / Q000097:blood; D009946:Organothiophosphorus Compounds / Q000494:pharmacology*; D010281:Parathyroid Hormone / Q000037:antagonists & inhibitors; D010282:Parathyroid Neoplasms / Q000188:drug therapy
D009946:Organothiophosphorus Compounds; D010281:Parathyroid Hormone; D008274:Magnesium; D004999:Amifostine